Transitioning from a disposable, prefilled autoinjector to a reusable pen meant designing for an even better experience.

The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...

More than half a million fans are expected to descend on Pittsburgh's North Shore and Point State Park for the 2026 NFL Draft ...

Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced merely at weekly cost of Rs 450 - making it one of the cheapest options ava ...

U.S. Insulin Delivery Devices Market was valued at USD 7.35 billion in 2025 and is expected to reach USD 15.74 billion by 2035 due to the exceptionally high diabetes prevalence.Austin, March 20, 2026 ...

A bipartisan group of senators is aiming to relieve that cost burden with the INSULIN Act , a bill to cap the cost of the ...

Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...

The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...

“Insulin injections remain a daily burden for many patients,” said Shingo Ito, an associate professor at Kumamoto University ...

(1,2) "Awiqli (R) is an important new option that meets a real need as the first FDA-approved, once-weekly basal insulin for adult patients with type 2 diabetes. It's helping to reframe what basal ...